The EMA has approved Penbraya for protection against invasive meningococcal disease and an update of the composition of two COVID-19 vaccines. Medscape Medical News
The EMA has approved Penbraya for protection against invasive meningococcal disease and an update of the composition of two COVID-19 vaccines. Medscape Medical News